These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
452 related items for PubMed ID: 15792176
1. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position. Yankah CA, Schubel J, Buz S, Siniawski H, Hetzer R. J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176 [Abstract] [Full Text] [Related]
2. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, Aranki SF, Couper GS, Cohn LH. Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753 [Abstract] [Full Text] [Related]
3. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years. Benhameid O, Jamieson WR, Castella M, Carrier M, Pomar JL, Germann E, Pellerin M, Brownlee RT. Thorac Cardiovasc Surg; 2008 Jun; 56(4):195-9. PubMed ID: 18481236 [Abstract] [Full Text] [Related]
4. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years. Jamieson WR, Fradet GJ, MacNab JS, Burr LH, Stanford EA, Janusz MT, Abel JG, Germann E, Cheung A. J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437 [Abstract] [Full Text] [Related]
5. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors. Minami K, Boethig D, Mirow N, Kleikamp G, Koertke H, Godehardt E, Koerfer R. J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383 [Abstract] [Full Text] [Related]
6. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome. Kuwaki K, Tsukamoto M, Komatsu K, Morishita K, Sakata J, Abe T. J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788 [Abstract] [Full Text] [Related]
7. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. Sjögren J, Gudbjartsson T, Thulin LI. J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900 [Abstract] [Full Text] [Related]
9. Lack of durability of the Mitroflow valve does not affect survival. Houel R, Le Besnerais P, Soustelle C, Kirsch M, Hillion ML, Loisance D. J Heart Valve Dis; 1999 Jul; 8(4):368-74; discussion 374-5. PubMed ID: 10461235 [Abstract] [Full Text] [Related]
10. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R. J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273 [Abstract] [Full Text] [Related]
11. Long-term durability and patient functional status of the Carpentier-Edwards Perimount pericardial bioprosthesis in the aortic position. Frater RW, Furlong P, Cosgrove DM, Okies JE, Colburn LQ, Katz AS, Lowe NL, Ryba EA. J Heart Valve Dis; 1998 Jan; 7(1):48-53. PubMed ID: 9502139 [Abstract] [Full Text] [Related]
12. Biological versus mechanical aortic prosthesis? A nineteen-year comparison in a propensity-matched population. Bottio T, Rizzoli G, Caprili L, Testolin L, Thiene G, Gerosa G. J Heart Valve Dis; 2005 Jul; 14(4):493-500. PubMed ID: 16116876 [Abstract] [Full Text] [Related]